1. P578: GILTERITINIB FOR RELAPSED/REFRACTORY FLT3 MUTATED ACUTE MYELOID LEUKEMIA A REAL-WORLD, MULTI-CENTER, MATCHED ANALYSIS. (23rd June 2022) Authors: Shimony, S.; Canaani, J.; Kugler, E.; Nachmias, B.; Ram, R.; Frisch, A.; Ganzel, C.; Vainstein, V.; Moshe, Y.; Aumann, S.; Yeshurun, M.; Ofran, Y.; Raanani, P.; Wolach, O. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P585: VENETOCLAX IN COMBINATION WITH INTENSIVE TREATMENT PROTOCOLS FOR PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA – A MULTICENTER REAL-WORLD ANALYSIS. (23rd June 2022) Authors: Wolach, O.; Frisch, A.; Shargian, L.; Yeshurun, M.; Apel, A.; Vainstein, V.; Moshe, Y.; Shimony, S.; Amit, O.; Bar On, Y.; Ofran, Y.; Raanani, P.; Nachmias, B.; Ram, R. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Validity of proposed DSM-5 diagnostic criteria for nicotine use disorder: results from 734 Israeli lifetime smokers. Issue 10 (October 2013) Authors: Shmulewitz, D.; Wall, M. M.; Aharonovich, E.; Spivak, B.; Weizman, A.; Frisch, A.; Grant, B. F.; Hasin, D. Journal: Psychological medicine Issue: Volume 43:Issue 10(2013) Page Start: 2179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗